Last reviewed · How we verify

NCT06049719

Reliabılıty,Validity Of The Turkish Version Of The NIH-Minimal Dataset

Completed Last updated 29 March 2024
What this trial tests

trial testing NIH Task Force's Recommended Multidimensional Minimal Dataset in Low Back Pain in 245 participants. Completed in 1 August 2023.

Timeline
1 June 2022
Primary endpoint
1 June 2023
1 August 2023

Quick facts

Lead sponsorGazi University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment245
Start date1 June 2022
Primary completion1 June 2023
Estimated completion1 August 2023
Sites3 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gazi University

Who can join

18 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study, we performed the Turkish version validity and reliability of the NIH Task Force's Recommended Multidimensional Minimal Dataset

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Gazi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06049719.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing